These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15555576)

  • 1. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.
    Iwanaga K; Takano H; Ohtsuka M; Hasegawa H; Zou Y; Qin Y; Odaka K; Hiroshima K; Tadokoro H; Komuro I
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1353-9. PubMed ID: 15555576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
    Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
    J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF does not improve systolic function in a rat model of acute myocardial infarction.
    Werneck-de-Castro JP; Costa-E-Sousa RH; de Oliveira PF; Pinho-Ribeiro V; Mello DB; Peçanha R; Mattos E; Olivares EL; Maia AC; Mill JG; Dos Santos Goldenberg RC; Campos-de-Carvalho AC
    Basic Res Cardiol; 2006 Nov; 101(6):494-501. PubMed ID: 16783485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes.
    Harada M; Qin Y; Takano H; Minamino T; Zou Y; Toko H; Ohtsuka M; Matsuura K; Sano M; Nishi J; Iwanaga K; Akazawa H; Kunieda T; Zhu W; Hasegawa H; Kunisada K; Nagai T; Nakaya H; Yamauchi-Takihara K; Komuro I
    Nat Med; 2005 Mar; 11(3):305-11. PubMed ID: 15723072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
    Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
    J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing.
    Beohar N; Flaherty JD; Davidson CJ; Vidovich M; Singhal S; Rapp JA; Erdogan A; Lee DC; Rammohan C; Brodsky A; Wu E; Pieper K; Virmani R; Bonow RO; Mehta J
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):257-66. PubMed ID: 17253607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
    Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
    Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
    Ohtsuka M; Takano H; Zou Y; Toko H; Akazawa H; Qin Y; Suzuki M; Hasegawa H; Nakaya H; Komuro I
    FASEB J; 2004 May; 18(7):851-3. PubMed ID: 15001565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF after myocardial infarction accelerates angiogenesis and reduces fibrosis in swine.
    Sato T; Suzuki H; Kusuyama T; Omori Y; Soda T; Tsunoda F; Shoji M; Iso Y; Koba S; Geshi E; Katagiri T; Kawachi K; Wakabayashi K; Takeyama Y
    Int J Cardiol; 2008 Jul; 127(2):166-73. PubMed ID: 17692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
    Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
    Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.